Network Pharmacology-Based Strategy Combined with Molecular Docking and in vitro Validation Study to Explore the Underlying Mechanism of Huo Luo Xiao Ling Dan in Treating Atherosclerosis

BACKGROUND: Huo Luo Xiao Ling Dan (HLXLD), a famous Traditional Chinese Medicine (TCM) classical formula, possesses anti-atherosclerosis (AS) activity. However, the underlying molecular mechanisms remain obscure. AIM: The network pharmacology approach, molecular docking strategy, and in vitro valida...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Taoli, Quan, Wenjuan, Peng, Sha, Yang, Dongmei, Liu, Jiaqin, He, Chaoping, Chen, Yu, Hu, Bo, Tuo, Qinhui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9166517/
https://www.ncbi.nlm.nih.gov/pubmed/35669282
http://dx.doi.org/10.2147/DDDT.S357483

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9166517/
https://www.ncbi.nlm.nih.gov/pubmed/35669282
http://dx.doi.org/10.2147/DDDT.S357483

Ejemplares similares